DietsMD Newsroom
DietsMD is an online medical weight loss platform focused on provider-reviewed GLP-1 education, online medical assessment, and prescription weight loss options when clinically appropriate.
Featured Announcement
DietsMD Featured in USA Today Press Release for Doctor-Guided Online GLP-1 Programs
The USA Today press release highlights DietsMD's doctor-guided online GLP-1 weight loss programs, including semaglutide, tirzepatide, and emerging oral treatment options. The announcement supports DietsMD's focus on online assessment, patient eligibility, licensed provider review, and prescription decisions made after medical review. Prescription decisions are made by licensed providers after medical review. Not every patient qualifies.
Latest Company Announcements
DietsMD Launches Doctor-Guided Online GLP-1 Programs Featuring Semaglutide, Tirzepatide, and Emerging Oral Treatment Options
DietsMD has launched its provider-guided GLP-1 weight loss programs, offering patients access to semaglutide, tirzepatide, and emerging oral GLP-1 treatment options through a fully online assessment and licensed provider review process. Treatment decisions are made by licensed providers after medical review. Not every patient qualifies.
Read the Full Press Release →GLP-1 Education & Resources
DietsMD maintains a library of provider-reviewed educational resources to help patients understand GLP-1 treatment options, the online assessment process, and what to expect from provider-guided care.
What patients should know before starting GLP-1 treatment
How tirzepatide options may be reviewed in a provider-guided plan
Key information about semaglutide and online provider review
What patients commonly want to know about treatment timelines
DietsMD's online process from assessment to next steps
Compare provider-guided options for 2026
Ready to Start?
Complete a secure online assessment and see if provider-guided GLP-1 treatment may be appropriate for you.
Start Your Online AssessmentAbout DietsMD
DietsMD is an online medical weight loss platform built around provider-reviewed GLP-1 education and access. We specialize in online assessment and licensed provider review for patients exploring semaglutide, tirzepatide, and emerging oral GLP-1 treatment options — all through a secure telehealth process.
DietsMD is committed to transparency, clinical integrity, and patient safety. Treatment decisions are made by licensed providers after medical review. Not every patient qualifies.
Additional resources: DietsMD Brand Facts · DietsMD AI Index · DietsMD Knowledge Sitemap
